Enjoy complimentary customisation on priority with our Enterprise License!
The oncology clinical trial market share is expected to increase by USD 4.22 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 6.70%.
This oncology clinical trial market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers oncology clinical trial market segmentation by design (interventional, observational, and expanded access) and geography (North America, Europe, Asia, and ROW). The oncology clinical trial market report also offers information on several market vendors, including F. Hoffmann-La Roche Ltd., Icon Plc, IQVIA Holdings Inc., Medpace Holdings Inc., Merck and Co. Inc., Novartis AG, Novotech (Australia) Pty Ltd., Parexel International Corp., Pivotal S.L.U, and Syneos Health Inc. among others.
Download the Free Report Sample to Unlock the Oncology Clinical Trial Market Size for the Forecast Period and Other Important Statistics
The increasing number of cancer cases across the globe is notably driving the oncology clinical trial market growth, although factors such as inefficient clinical trial design for oncology may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the oncology clinical trial industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Oncology Clinical Trial Market Driver
The number of cancer cases is rising on a global level due to increased pollution and frequent changes in lifestyle. Exposure to carcinogens has increased as the global air quality index has degraded. Pharmaceutical companies and various government organizations are developing new and improved treatments for multiple types of cancers and scheduling oncology clinical trials to get the treatments approved by relevant agencies, which, in turn, will drive the demand for oncology clinical trials during the forecast period.
Key Oncology Clinical Trial Market Challenge
Clinical trials are subject to errors, and oncology clinical trials need to be thorough. The data collection method may be inefficient, and the researchers may not get full disclosure from patients participating in trials. This leads to misinformation resulting in wrongful conclusions, which hamper the oncology study for which the clinical trial was conducted. Other factors such as inappropriate selection of clinical trial candidates and error in clinical trial design may damage the study. Hence, the global market for oncology clinical trials can be restricted by inefficient clinical trial designs.
This oncology clinical trial market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the oncology clinical trial market encompasses successful business strategies deployed by the key vendors. The oncology clinical trial market is fragmented and the vendors are deploying growth strategies such as focusing on product innovation and spending in research and development activities to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The oncology clinical trial market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Design
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.